Galletta Christopher
SEC insider (Form 3/4/5 filer). CIK 0001486099. Officer at Trevi Therapeutics, Inc. (TRVI). 6 reported Form 4/5 transactions since Sep 2024; latest on Feb 19, 2026. Located in NEW HAVEN, CT.
Companies Galletta Christopher has filed insider reports for
- Trevi Therapeutics, Inc. (TRVI): Officer, See Remarks
Galletta Christopher
CIK: 0001486099
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Trevi Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Feb 19, 2026TRVI
Trevi Therapeutics, Inc.
AwardDirectStock Option (right to buy)
35K shares- - Dec 2, 2025TRVI
Trevi Therapeutics, Inc.
ExerciseDirect4.2K shares at avg. $0.51$2K - May 31, 2025TRVI
Trevi Therapeutics, Inc.
AwardDirectPerformance Stock Option (right to buy)
8.6K shares- - Mar 10, 2025TRVI
Trevi Therapeutics, Inc.
AwardDirectPerformance Stock Option (right to buy)
4.6K shares- - Feb 18, 2025TRVI
Trevi Therapeutics, Inc.
AwardDirectStock Option (right to buy)
41K shares- - Dec 13, 2024TRVI
Trevi Therapeutics, Inc.
ExerciseDirect15K shares at avg. $0.51$8K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 19, 2026 | TRVI Trevi Therapeutics, Inc. | Award Stock Option (right to buy) | 35,000 | - | - | Direct |
| Dec 2, 2025 | TRVI Trevi Therapeutics, Inc. | Exercise | 4,225 | $0.51 | $2,159 | Direct |
| May 31, 2025 | TRVI Trevi Therapeutics, Inc. | Award Performance Stock Option (right to buy) | 8,550 | - | - | Direct |
| Mar 10, 2025 | TRVI Trevi Therapeutics, Inc. | Award Performance Stock Option (right to buy) | 4,560 | - | - | Direct |
| Feb 18, 2025 | TRVI Trevi Therapeutics, Inc. | Award Stock Option (right to buy) | 41,000 | - | - | Direct |
| Dec 13, 2024 | TRVI Trevi Therapeutics, Inc. | Exercise | 15,000 | $0.51 | $7,665 | Direct |
1-6 of 6 transactions